Press Information

Director/PDMR Shareholding

Dundee, Scotland, 13 January 2010: It was today intimated to Axis-Shield plc that Dr John Brown, Non-executive Director, has purchased 7,500 Ordinary shares of 35 pence each at a price of 410 pence per share. This increases Dr Brown`s beneficial interest from 0 Ordinary shares to 7,500 Ordinary shares. 

This announcement requires to be made on the London Stock Exchange and is repeated in Norway for Oslo Stock Exchange purposes in accordance with the 'equivalent information' rule (Rule DTR 2.4).

Enquiries:

Notes to Editors:

About Axis-Shield

Axis-Shield is an international in vitro diagnostics company, headquartered in Dundee with R&D and manufacturing bases in Dundee and Oslo. The Group specialises in the supply of instruments and tests for the rapidly growing physician's office testing market and the development, manufacture and marketing of innovative proprietary diagnostics kits in areas of clinical need, including cardiovascular and neurological diseases, rheumatoid arthritis, and diabetes. 

For more information on Axis-Shield, please refer to www.axis-shield.com